Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA.

Literature DB >> 23007743

Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA.

Miguel A González-Gay, Carlos González-Juanatey.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23007743 DOI： 10.1038/nrrheum.2012.158

Source DB: PubMed Journal: Nat Rev Rheumatol ISSN： 1759-4790 Impact factor: 20.543

× No keyword cloud information.

10 in total

1. Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.

Authors: Frank C Huvers; Calin Popa; Mihai G Netea; Frank H J van den Hoogen; Cees J Tack
Journal: Ann Rheum Dis Date: 2007-04 Impact factor: 19.103

Review 2. Rheumatoid arthritis: a disease associated with accelerated atherogenesis.

Authors: Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Javier Martin
Journal: Semin Arthritis Rheum Date: 2005-08 Impact factor: 5.532

Review 3. Insulin resistance: definition and consequences.

Authors: H E Lebovitz
Journal: Exp Clin Endocrinol Diabetes Date: 2001 Impact factor: 2.949

Review 4. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy.

Authors: Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Tomas R Vazquez-Rodriguez; Jose A Miranda-Filloy; Javier Llorca
Journal: Ann N Y Acad Sci Date: 2010-04 Impact factor: 5.691

5. TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients.

Authors: José A Miranda-Filloy; Javier Llorca; Beatriz Carnero-López; Carlos González-Juanatey; Ricardo Blanco; Miguel A González-Gay
Journal: Clin Exp Rheumatol Date: 2012-12-17 Impact factor: 4.473

6. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.

Authors: Patrick H Dessein; Milton Tobias; Martin G Veller
Journal: J Rheumatol Date: 2006-10-15 Impact factor: 4.666

Review 7. Abdominal obesity and metabolic syndrome.

Authors: Jean-Pierre Després; Isabelle Lemieux
Journal: Nature Date: 2006-12-14 Impact factor: 49.962

8. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.

Authors: M A Gonzalez-Gay; J M De Matias; C Gonzalez-Juanatey; C Garcia-Porrua; A Sanchez-Andrade; J Martin; J Llorca
Journal: Clin Exp Rheumatol Date: 2006 Jan-Feb Impact factor: 4.473

9. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.

Authors: Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Ingrid Avalos; Tuulikki Sokka; Paolo Raggi; Theodore Pincus; C Michael Stein
Journal: Arthritis Rheum Date: 2008-07

10. Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.

Authors: Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Vasileios F Panoulas; Peter Nightingale; Yiannis Koutedakis; George D Kitas
Journal: Arthritis Res Ther Date: 2012-07-05 Impact factor: 5.156

10 in total

6 in total

1. The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1β.

Authors: Hidetoshi Fujita; Naoko Yagishita; Satoko Aratani; Tomoko Saito-Fujita; Saori Morota; Yoshihisa Yamano; Magnus J Hansson; Masato Inazu; Hiroko Kokuba; Katsuko Sudo; Eiichi Sato; Ko-Ichi Kawahara; Fukami Nakajima; Daisuke Hasegawa; Itsuro Higuchi; Tomoo Sato; Natsumi Araya; Chie Usui; Kenya Nishioka; Yu Nakatani; Ikuro Maruyama; Masahiko Usui; Naomi Hara; Hiroyuki Uchino; Eskil Elmer; Kusuki Nishioka; Toshihiro Nakajima
Journal: EMBO J Date: 2015-02-19 Impact factor: 11.598